1. Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer
- Author
-
Palatnik, Anna, Ye, Shuyun, Kendziorski, Christina, Iden, Marissa, Zigman, Jessica S., Hessner, Martin J., and Rader, Janet S.
- Subjects
0301 basic medicine ,Staphylococcus ,lcsh:Medicine ,Cervical Cancer ,Pathology and Laboratory Medicine ,Biochemistry ,Microbiology ,Metastasis ,Lymphatic System ,03 medical and health sciences ,0302 clinical medicine ,Diagnostic Medicine ,Gene Types ,Basic Cancer Research ,Genetics ,Medicine and Health Sciences ,Cancer Detection and Diagnosis ,Staphylococcus Aureus ,Non-coding RNA ,lcsh:Science ,Microbial Pathogens ,Multidisciplinary ,Biology and life sciences ,Bacteria ,lcsh:R ,Organisms ,Cancers and Neoplasms ,Gene regulation ,Bacterial Pathogens ,Nucleic acids ,MicroRNAs ,030104 developmental biology ,Oncology ,Medical Microbiology ,030220 oncology & carcinogenesis ,RNA ,Regulator Genes ,lcsh:Q ,Gene expression ,Lymph Nodes ,Anatomy ,Pathogens ,Gynecological Tumors ,Research Article - Abstract
Objective Tumor cells that escape local tissue control can convert inflammatory cells from tumor suppressors to tumor promoters. Moreover, soluble immune-modulating factors secreted from the tumor environment can be difficult to identify in patient serum due to their low abundance. We used an alternative strategy to infer a metastatic signature induced by sera of cervical cancer patients. Methods Sera from patients with local and metastatic cervical cancer were used to induce a disease-specific transcriptional signature in cultured, healthy peripheral blood mononuclear cells (PBMCs). An empirical Bayesian method, EBarrays, was used to identify differentially expressed (DE) genes with a target false discovery rate of
- Published
- 2017